1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 386 F.Supp.2d
  5. 386 F.Supp.2d 549 (2005)
 

APOTEX INC. v. SANOFI-SYNTHELABO

No. 05 CIV. 3965(SHS).

386 F.Supp.2d 549 (2005)

APOTEX INC.; and Apotex Corp, Plaintiffs, v. SANOFI-SYNTHELABO; Sanofi-Synthelabo, Inc.; and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership, Defendants.

United States District Court, S.D. New York.

September 12, 2005.

Attorney(s) appearing for the Case

Karen Jill Bernstein, Amster, Rothstein & Ebenstein LLC, New York City, for Plaintiffs.

David Noah Greenwald, Evan R. Chesler, Richard J. Stark, Cravath, Swaine & Moore LLP, New York City, for Defendants.

ORDER

STEIN, District Judge.

Plaintiffs Apotex, Inc. and Apotex Corp. (collectively "Apotex") bring this litigation pursuant to the Declaratory Judgment Act, 28 U.S.C. §§ 2201, 2202, seeking a declaration that U.S. Patent No. 4,847,265 (the " '265 patent") is invalid because the named inventors, defendants' patent agents, and an unnamed inventor intentionally withheld or omitted material information during the prosecution of the patent before...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases